Chinese researchers find new potential anti-diabetic drug target

English Español Français العربية Русский

RSS Newsletters

Radio TV

LANGUAGE
English Español Français العربية Русский Documentary CCTV+

Radio TV

Download

Translating...

Content is automatically generated by Microsoft Azure Translator Text API. CGTN is not responsible for any of the translations.

A physician helps a patient to test blood glucose. /CFP

Researchers from China's Peking University have found a new potential drug target for improving the effectiveness of diabetes treatment.

Bacteroides spp. microbial dipeptidyl peptidase 4 (DPP4) from the gut microbiota is believed to be an important therapeutic target for the management of type 2 diabetes, according to the researchers.

DPP4 can degrade the host's glucagon and contribute to compromising glucose homeostasis, as indicated in the study published in Science on August 4.

Research published in the journal Science, August 4, 2023. /Science screenshot

The researchers also found that the enrichment of the peptidase in the host's body will significantly reduce the clinical efficacy of Sitagliptin, a commonly used diabetes treatment medication, as Sitagliptin cannot inhibit the activity of DPP4 effectively.

Efforts are underway to seek methods to inhibit the enzyme activity of DPP4, which holds the potential to enhance the efficacy of existing medications and even discover new treatment approaches.

The discovery is expected to have significant implications for further understanding the pathogenesis of diabetes and for enhancing the efficacy of related drug treatments, according to the study.

Source(s): Xinhua News Agency

MORE FROM CGTN

2nm chips explainer: The race to shrink tech explained

{"type":2,"value":"CGTN","commentator":[{"id":407,"name":"Gong Zhe","photograph":"https://news.cgtn.com/editor/2020-09-28/43/image/1601277199374.png","url":"https://www.cgtn.com/stars/Gong-Zhe.html"}],"valueShow":false,"commentatorShow":true}

Technology

14:15, 06-Apr-2025